BMEYE’s Heart Monitoring Technology May Set A New Standard In Patient Care
During an average life span of 70 years, the human heart will pump more than 400 million litres of blood.
Member Spotlight
Wound Management Technologies Addresses Multi Billion Dollar Wound Care Market With CellerateRX
Wound Management’s FDA approved product has become a primary treatment for all types of wounds and sparked interest in the investment community.
The Long and Short of CerviLenz Prenatal Technology
Cervilenz has developed an innovative low cost, single use medical device that accurately measures a pregnant woman’s cervical length, which is the best indicator of preterm birth risk.
InTUUN’s Cooperative Health Record Integration Puts the Patient First
In this age where more and more modes of communication are being created, it is natural to find innovative ways to connect health professionals and patients.
Provectus Pharmaceuticals Uses Old Drug To Actualize Novel Therapeutics for Cancer and Skin Disorders
Provectus Pharmaceuticals develops a powerful drug pipeline with minimal side effects, including a cancer drug that targets cancer tissue, as well as…
Bio-Path Holdings To Present Powerful Drug Delivery Technology at OneMedForum NY 2011
Bio-Path Holdings has developed a powerful drug delivery technology that utilizes cell-like drug carriers, termed liposomes, which avoid drug breakdown.
New Breakthrough Technology May Reverse Fatal Blood Vessel Condition
ADS Biotechnology has developed a breakthroughtechnology that upon administration immediately prevents any further blood vessel leakage, thereby effectively treating and reversing CLS.
Prochon Biotech May Restore Quality of Life For Millions Who Suffer From Cartilage Injury
Deteriorating or damaged cartilage is a force to be reckoned with. But ProChon Biotech’s vision is to lead in the innovation of regenerative musculoskeletal technologies.
Adherex Enrolls First Patient in Clinical Trial For Metastatic Breast Cancer
In 2010, NCI estimated that 207,090 women were diagnosed with breast cancer, while 39,840 women likely died from the disease.
QR Pharma Returns to OneMedForum To Present Alzheimer’s Technology
OR Pharma previously presented at OneMedForum San Francisco and will return in June to preset their technology at OneMedForum NY 2011.